全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Status of the Gastric Mucosa with Endoscopically Diagnosed Gastrointestinal Stromal Tumor

DOI: 10.1155/2014/429761

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background. Since gastrointestinal stromal tumor (GIST) is a mesenchymal submucosal tumor, the endosonographic, CT, and MRI features of gastric GISTs have been widely investigated. However, the GIST-bearing gastric mucosa status has not been reported. Objective. To characterize the GIST-bearing gastric mucosa status in terms of the degree of inflammation and atrophy, assessed endoscopically. Subjects and Methods. The subjects were 46 patients with submucosal tumors (histologically proven gastric GISTs) who had undergone upper gastrointestinal endoscopy in our hospital between April 2007 and September 2012. They were retrospectively evaluated regarding clinicopathological features, the endoscopically determined status of the entire gastric mucosa (presence or absence and degree of atrophy), presence or absence and severity of endoscopic gastritis/atrophy (A-B classification) at the GIST site, and presence or absence of H. pylori infection. Results. Twenty-three patients had no mucosal atrophy, but 17 and 6 had closed- and open-type atrophy, respectively. Twenty-six, 5, 12, 1, 1, and 1 patients had grades B0, B1, B2, B3, A0, and A1 gastritis/atrophy at the lesion site, respectively, with no grade A2 gastritis/atrophy. Conclusion. The results suggest that gastric GISTs tend to arise in the stomach wall with H. pylori-negative, nonatrophic mucosa or H. pylori-positive, mildly atrophic mucosa. 1. Introduction Gastric gastrointestinal stromal tumor (GIST) is a mesenchymal tumor arising from the muscularis propria of the gastric wall and is covered with normal mucosa, giving the endoscopic appearance of a submucosal tumor with bridging folds. Since gastric GIST is a submucosal tumor, its endosonographic, CT, and MRI features have been widely investigated [1–4]. However, the status of the GIST-bearing gastric mucosa itself has not been reported. Based on our experience, many GIST patients often show no evidence of H. pylori infection, gastritis, or mucosal atrophy on upper gastrointestinal endoscopy, and even H. pylori-infected patients may show mild gastritis in the background gastric mucosa. We consider that it is necessary to evaluate the GIST-bearing gastric mucosa using available data before testing the validity of this empirical rule and investigate the reason for it, if it is valid. In this study, we retrospectively evaluated patients with submucosal tumors (histologically proven gastric GISTs) regarding the age, gender, site and size of the lesion, risk classification of GISTs, presence or absence and degree of endoscopic atrophy in the entire gastric

References

[1]  J. Yoshino, K. Inui, T. Wakabayashi, et al., “Diagnosis and assessment of malignancy for digestive GIST–endoscopic ultrasonography and EUS-guided fine needle aspiration,” Stomach and Intestine, vol. 43, pp. 163–171, 2008.
[2]  S. Ohashi, S. Okamura, F. Urano, M. Maeda, H. Goto, and Y. Niwa, “Clinical malignancy risk of gist assessed by endoscopic ultrasonography,” Digestive Endoscopy, vol. 18, no. 4, pp. 256–262, 2006.
[3]  Tateishi U. Multi-Modality Allows Diagnosis of GIST, Stomach and Intestine, vol. 43, Igaku-Shoin Ltd., Tokyo, Japan, 2008, (in Japanese with English abstract).
[4]  Y. R. Choi, S. H. Kim, S. A. Kim, et al., “Differentiation of Large ( ?cm) gastrointestinal stromal tumors from benign subepithelial tumors in the stomach: radiologist performance using CT,” European Journal of Radiology, vol. 83, pp. 250–260, 2014.
[5]  Japanese Research Society for Gastric Cancer, Japanese Classification of Gastric Carcinoma, Kanehara & Company, Tokyo, Japan, 2010.
[6]  K. Kimura and T. Takemoto, “An endoscopic recognition of the atrophic border and its significance in chronic gastritis,” Endoscopy, vol. 3, article 87, 1969.
[7]  K. Yagi, J. Watanabe, A. Nakamura, and A. Sekine, “Magnifying views of Gastritis-AB classification,” Stomach and Intestine, vol. 42, pp. 697–704, 2007 (Japanese).
[8]  Y. Fujimoto, Y. Nakanishi, K. Yoshimura, and T. Shimoda, “Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients,” Gastric Cancer, vol. 6, no. 1, pp. 39–48, 2003.
[9]  S. Shiota, K. Murakami, T. Fujioka, and Y. Yamaoka, “Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective,” Expert Review of Gastroenterology and Hepatology, vol. 4, no. 2, pp. 149–156, 2010.
[10]  M. Asaka, T. Kimura, M. Kudo et al., “Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population,” Gastroenterology, vol. 102, no. 3, pp. 760–766, 1992.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413